Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Mar 13, 2019
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2019-03-11$6.00/sh−1,565$9,390→ 11,249 total
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.
- [F2]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2018.